Showcases Stock ranks

Bristol-Myers Squibb Company (BMY)
59.14  0.16 (0.27%) 07-02 16:00
Open: 59.3 Pre. Close: 58.98
High: 59.64 Low: 58.75
Volume: 10,864,120 Market Cap: 133,815M
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humaniz
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 59.674 - 59.979 59.979 - 60.213
Low: 58.045 - 58.368 58.368 - 58.615
Close: 58.641 - 59.18 59.18 - 59.594
Stock Technical Analysis
Target: Six months: 72.61
One year: 84.81
Support: Support1: 57.16
Support2: 54.07
Resistance: Resistance1: 62.17
Resistance2: 72.61
Pivot: 57.48
Moving Averages: MA(5): 58.54
MA(20): 58.14
MA(100): 59.17
MA(250): 56.47
MACD: MACD(12,26): -0.35
Signal(12,26,9): -0.66
%K %D: %K(14,3): 80.14
%D(3): 65.60
RSI: RSI(14): 52.39
52-Week: High: 68.34
Low: 42.48
Change(%): 29.2
Average Vol(K): 3-Month: 1603212
10-Days: 1845317
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

BMY has closed below upper band by 14.9%. Bollinger Bands are 42.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Fri, 03 Jul 2020
Bristol-Myers Squibb: Growth And Valuation Trump Other Concerns - Seeking Alpha

Thu, 02 Jul 2020
Were Hedge Funds Right About Piling Into Bristol Myers Squibb Company (BMY)? - Yahoo Finance

Thu, 02 Jul 2020
Bristol Myers Squibb: Insider Anticipating Significant Shareholder Value Creation From Merger - Seeking Alpha

Fri, 26 Jun 2020
Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Special Call (Transcript) - Seeking Alpha

Wed, 01 Jul 2020
Is Bristol Myers (BMY) a Solid Growth Stock? 3 Reasons to Think " Yes " - Yahoo Finance

Tue, 30 Jun 2020
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug ManufacturersGeneral
Shares Out. (M) 2260.00
Shares Float (M) 2260.00
% Held by Insiders 0.11
% Held by Institutions 79.09
Shares Short (K) 30590
Shares Short Prior Month (K) 34430
Stock Financials
EPS 0.510
Book Value (p.s.) 22.060
Profit Margin 3.08
Operating Margin 24.63
Return on Assets (ttm) 5.8
Return on Equity (ttm) 3.0
Qtrly Rev. Growth 82.1
Gross Profit (p.s.) 8.376
Sales Per Share 13.721
EBITDA (p.s.) 5.124
Qtrly Earnings Growth
Operating Cash Flow (M) 10570.00
Levered Free Cash Flow (M) 9500.00
Stock Valuation
PE Ratio 115.98
PEG Ratio 1.01
Price to Book value 2.68
Price to Sales 4.31
Price to Cash Flow 12.65
Stock Dividends
Dividend 1.720
Dividend Yield 0.03
Dividend Growth 1.800

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator